1. Home
  2. ITOS vs ISPR Comparison

ITOS vs ISPR Comparison

Compare ITOS & ISPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ITOS
  • ISPR
  • Stock Information
  • Founded
  • ITOS 2011
  • ISPR 2019
  • Country
  • ITOS United States
  • ISPR United States
  • Employees
  • ITOS N/A
  • ISPR N/A
  • Industry
  • ITOS Biotechnology: Biological Products (No Diagnostic Substances)
  • ISPR Medicinal Chemicals and Botanical Products
  • Sector
  • ITOS Health Care
  • ISPR Health Care
  • Exchange
  • ITOS Nasdaq
  • ISPR Nasdaq
  • Market Cap
  • ITOS 381.2M
  • ISPR 152.0M
  • IPO Year
  • ITOS 2020
  • ISPR 2023
  • Fundamental
  • Price
  • ITOS $10.07
  • ISPR $2.70
  • Analyst Decision
  • ITOS Hold
  • ISPR Strong Buy
  • Analyst Count
  • ITOS 6
  • ISPR 2
  • Target Price
  • ITOS $10.60
  • ISPR $10.00
  • AVG Volume (30 Days)
  • ITOS 871.5K
  • ISPR 95.0K
  • Earning Date
  • ITOS 08-07-2025
  • ISPR 05-12-2025
  • Dividend Yield
  • ITOS N/A
  • ISPR N/A
  • EPS Growth
  • ITOS N/A
  • ISPR N/A
  • EPS
  • ITOS N/A
  • ISPR N/A
  • Revenue
  • ITOS $35,000,000.00
  • ISPR $144,700,345.00
  • Revenue This Year
  • ITOS N/A
  • ISPR N/A
  • Revenue Next Year
  • ITOS N/A
  • ISPR $35.39
  • P/E Ratio
  • ITOS N/A
  • ISPR N/A
  • Revenue Growth
  • ITOS 177.89
  • ISPR N/A
  • 52 Week Low
  • ITOS $4.80
  • ISPR $2.09
  • 52 Week High
  • ITOS $18.13
  • ISPR $7.93
  • Technical
  • Relative Strength Index (RSI)
  • ITOS 62.61
  • ISPR 51.61
  • Support Level
  • ITOS $9.95
  • ISPR $2.09
  • Resistance Level
  • ITOS $10.21
  • ISPR $3.25
  • Average True Range (ATR)
  • ITOS 0.15
  • ISPR 0.30
  • MACD
  • ITOS -0.09
  • ISPR 0.07
  • Stochastic Oscillator
  • ITOS 53.33
  • ISPR 52.59

About ITOS iTeos Therapeutics Inc.

ITeos Therapeutics Inc is a biopharmaceutical company. It designs novel product candidates with optimized pharmacologic properties to improve clinical outcomes by restoring the immune response against cancer. The company's product candidates include EOS-850 which is an Adenosine A2A receptor-specific antagonist, and EOS-448 which is an ADCC-enabled, anti-TIGIT immune checkpoint blocking antibody among other drug candidates.

About ISPR Ispire Technology Inc.

Ispire Technology Inc is engaged in the research and development, design, commercialization, sales, marketing, and distribution of branded e-cigarettes and cannabis vaping products. The company sells its cannabis vaping in the United States, Europe, Canada, and South Africa.

Share on Social Networks: